ADA 2023: Obesity Treatment Shifts from Weight Loss to Long-Acting, Oral Therapies, and Muscle Preservation
At the recent American Diabetes Association (ADA) annual scientific sessions, South Korean biotechnology firms—collectively known as “K-Bio”—unveiled a shift in obesity pharmacotherapy. Moving beyond simple weight loss metrics, the focus ... Read More